FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Jacobs Jeffrey Scott
2. Issuer Name and Ticker or Trading Symbol

Ceridian HCM Holding Inc. [ CDAY ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Head of Acct & Fin Reporting
(Last)          (First)          (Middle)

C/O CERIDIAN HCM HOLDING INC., 3311 E. OLD SHAKOPEE ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)

5/18/2020
(Street)

MINNEAPOLIS, MN 55425
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 5/18/2020  M  3000 (1)A$16.82 5194 (2)D  
Common Stock 5/18/2020  S  3000 (1)D$67.00 2194 (2)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option (right to buy) $17.58            (3)12/8/2025 Common Stock 500  500 D  
Option (right to buy) $16.82 5/18/2020  M     3000 (1)  (4)12/31/2026 Common Stock 3000  (5)4125 D  
Option (right to buy) $19.04            (6)12/20/2027 Common Stock 5000  5000 D  
Option (right to buy) $22.00            (7)4/25/2028 Common Stock 32610  32610 D  
Option (right to buy) $44.91            (8)2/8/2029 Common Stock 712  712 D  
Option (right to buy) $49.93            (9)3/20/2029 Common Stock 8396  8396 D  
Option (right to buy) $65.26            (10)5/8/2030 Common Stock 14299  14299 D  
Performance Units  (11)           (11)3/1/2021 Common Stock 459  459 D  

Explanation of Responses:
(1) The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
(2) Includes (i) 441 shares of common stock, (ii) 221 shares issuable pursuant to Restricted Stock Units, granted on February 28, 2020, that vest in three annual installments beginning on February 28, 2021, and (iii) 1,532 shares that are issuable pursuant to Restricted Stock Units, granted on May 8, 2020, that vest in three annual installments beginning on May 8, 2021.
(3) Fully vested and exercisable.
(4) Consists of 4,750 vested and exercisable options, of which 3,000 are being exercised pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, and 2,375 options that vest and become exercisable on December 31, 2020.
(5) Not Applicable
(6) Consists of 2,500 vested and exercisable options and 2,500 options that vest and become exercisable in two annual installments beginning on December 20, 2020.
(7) Consists of 16,304 vested and exercisable options and 16,306 options that vest and become exercisable in two annual installments beginning on April 25, 2021.
(8) Consists of 178 vested and exercisable options and 534 options that vest and become exercisable in three annual installments beginning on February 8, 2021.
(9) Consists of 2,099 vested and exercisable options and 6,297 options that vest and become exercisable in three annual installments beginning on March 20, 2021.
(10) These options vest and become exercisable in four annual installments beginning on May 8, 2021.
(11) Each performance unit, granted on February 28, 2020, represents a contingent right to receive up to 1.25 shares of Common Stock. The performance units vest upon satisfaction of Cloud Revenue and Adjusted EBITDA margin targets under the Company's 2020 Management Incentive Plan.

Remarks:
For Jeffrey Jacobs pursuant to the Power of Attorney previously filed.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Jacobs Jeffrey Scott
C/O CERIDIAN HCM HOLDING INC.
3311 E. OLD SHAKOPEE ROAD
MINNEAPOLIS, MN 55425


Head of Acct & Fin Reporting

Signatures
/s/ William E. McDonald5/19/2020
**Signature of Reporting PersonDate

Ceridian HCM (NYSE:CDAY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Ceridian HCM Charts.
Ceridian HCM (NYSE:CDAY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Ceridian HCM Charts.